SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001047469-19-001440
Filing Date
2019-03-20
Accepted
2019-03-20 07:42:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 14D9 a2238152zsc14d9.htm SC 14D9 328808
2 EX-99.(E)(3) a2238152zex-99_e3.htm EX-99.(E)(3) 91002
3 G406437.JPG g406437.jpg GRAPHIC 9125
  Complete submission text file 0001047469-19-001440.txt   434082
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filed by) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Subject) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-81991 | Film No.: 19693577
SIC: 2836 Biological Products, (No Diagnostic Substances)